This paper brings together the study of transnational flows in global health and the gendering of technological artefacts. It does so through a case study of vaginal microbicides for HIV prevention, which have commonly been advocated for as a tool for women’s empowerment in parts of the world where HIV is most prevalent, namely sub-Saharan Africa. Drawing on fieldwork in the UK and Zambia, I argue that there is nothing inherently gendered about this ‘woman-controlled’ technology. Combining the notions of scripting and ‘making things public’, I demonstrate the political nature of transnational technology design and testing in the field of sexual health. Rather than framing this in terms of ethical debates, as is frequently the case in studies about the ‘global South’, I ground the analysis in the scripting and de-scripting of technologies and users. By focusing on how things are made public in HIV prevention, I draw attention to the normative, transformative and political potentials of new technologies, such as microbicides, and discuss the implications for their therapeutic success.
Abdool KarimQAbdool KarimSSFrohlichJAGroblerACBaxterC. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science329(5996): 1168–1174.
2.
AkrichM (1992) The de-scription of technical objects. In: BijkerWELawJ (eds) Shaping Technology/Building Society. Studies in Sociotechnical Change. Cambridge, MA: MIT Press, 205–224.
3.
AndersonW (2002) Introduction: Postcolonial technoscience. Social Studies of Science32: 643–658.
4.
AndersonWAdamsV (2007) Pramoedya’s chickens: Postcolonial studies of technoscience. In: HackettEJAmsterdamskaOLynchMWajcmanJ (eds) Handbook of Science and Technology Studies, 3rd edition. Cambridge, MA: MIT Press, 181–204.
BaggaleyRFWhiteRGBoilyM (2010) HIV transmission risk through anal intercourse: Systematic review, meta-analysis and implications for HIV prevention. International Journal of Epidemiology39(4): 1048–1063.
8.
BiehlJ (2007) Pharmaceuticalization: AIDS treatment and global health politics. Anthropological Quarterly4: 1083–1126.
9.
BinkaF (2005) North–South research collaborations: A move towards a true partnership?Tropical Medicine & International Health10(3): 207–209.
10.
BrayF (2007) Gender and technology. Annual Review of Anthropology36: 1–21.
11.
ByrneB (1994) Gender profile of Zambia. Report No. 29, BRIDGE (Development-Gender), Brighton, Institute of Development Studies, University of Sussex. Available at: www.aletta.nu/epublications/1994/gender_profile_of_zambia.pdf (accessed 7 July 2012).
12.
CoreaG (1985) The Mother Machine: Reproductive Technologies from Artificial Insemination to Artificial Wombs. New York: Harper and Row.
13.
CorriganO (2003) Empty ethics: The problem with informed consent. Sociology of Health & Illness25(3): 768–792.
14.
CutlerBJustmanJ (2008) Vaginal microbicides and the prevention of HIV transmission. Lancet Infectious Diseases8(11): 685–697.
15.
De LaetMMolA (2000) The Zimbabwe bush pump: Mechanics of a fluid technology. Social Studies of Science30: 225–263.
16.
DoyalLNaidooVWiltonT (1994) AIDS: Setting a Feminist Agenda. London: Taylor & Francis.
17.
DritsasLS (2003) Book review: Science and Society in Southern Africa (DubowS, ed.). Science, Technology, & Human Values28: 331–334.
EhrenreichBEnglishD (1979) For Her Own Good: 150 Years of the Experts’ Advice to WomenLondon: Pluto Press.
20.
EpsteinS (1995) The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Science, Technology, & Human Values20(4): 408–437.
21.
EpsteinS (1996) Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley, CA: University of California Press.
22.
EpsteinS (2007) ‘The badlands of desire’: Sex research, cultural scenarios, and the politics of knowledge production. In: KimmelM (ed.) The Sexual Self: The Construction of Sexual Scripts. Nashville: Vanderbilt University Press, 249–263.
23.
EpsteinS (2010) The great undiscussable: Anal cancer, HPV, and gay men’s health. In: WailooKLivingstonJEpsteinSAronowitzR (eds) Three Shots at Prevention: The HPV Vaccine and the Politics of Medicine’s Simple Solutions. Baltimore: The Johns Hopkins University Press, 61–90.
FriedmanSRRossiD (2011) Dialectical theory and the study of HIV/AIDS and other epidemics. Dialectical Anthropology35(4): 403–427.
26.
GrintKGillR (1995) The Gender–Technology Relation: Contemporary Theory and Research. London: Taylor & Francis.
27.
GrintKWoolgarS (1995) On some failures of nerve in constructivist and feminist analyses of technology. Science, Technology, & Human Values20(3): 286–310.
28.
HalperinDT (1999) Heterosexual anal intercourse: Prevalence, cultural factors, and HIV infection and other health risks, part 1. AIDS Patient Care and STDs12(12): 717–730.
29.
HeiseLEliasC (1995) Transforming AIDS prevention to meet women’s needs: A focus on developing countries. Social Science & Medicine40(7): 931–943.
JasanoffS (2004) States of Knowledge. The Co-production of Science and Social Order. London and New York: Routledge.
32.
JasanoffS (2005) ‘Let them eat cake’: GM foods and the democratic imagination. In: LeachMScoonesIWynneB (eds) Science and Citizens. London and New York: Zed Books, 183–198.
33.
KooHPWoodsongCDalberthBTViswanathanMSimons-RudolphA (2005) Context of acceptability of topical microbicides: Sexual relationships. Journal of Social Issues61(1): 67–93.
34.
KreissJKKoechDPlummerFAHolmesKKLightfooteMPiotP. (1986) AIDS virus infection in Nairobi prostitutes: Spread of the epidemic to East Africa. New England Journal of Medicine314(7): 414–418.
LatourB (1988) The Pasteurization of France. Cambridge, MA: Harvard University Press.
37.
LatourB (2005) From realpolitik to dingpolitik – or how to make things public. In: LatourBWeibelP (eds) Making Things Public: Atmospheres of Democracy. Cambridge, MA: ZKM/MIT Press, 14–41.
38.
LynchM (2008) Editorial. Social Studies of Science38(1): 5–6.
39.
MayC (2006) Mobilising modern facts: Health technology assessment and the politics of evidence. Sociology of Health & Illness28(5): 513–532.
40.
McCormackSRamjeeGKamaliAReesHCrookAMGafosM. (2010) PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): A phase 3, randomised, double-blind, parallel-group trial. Lancet376: 1329–1337.
41.
McGoeyLReissJWahlbergA (2011) The global health complex. BioSocieties6(1): 1–9.
42.
McGowanI (2008) Rectal microbicides: A new focus for HIV prevention. Sexually Transmitted Infections84: 413–417.
43.
MellströmU (2009) The intersection of gender, race and cultural boundaries, or why is computer science in Malaysia dominated by women?Social Studies of Science39: 885–907.
44.
Microbicides Development Programme. (2009) What are microbicides? Available at: http://www.mdp.mrc.ac.uk/what.html (accessed 18 March 2009).
45.
MontgomeryCMGafosMLeesSMorarNSMweembaOSsaliA. (2010) Re-framing microbicide acceptability: Findings from the MDP301 trial. Culture, Health & Sexuality12(6): 649–662.
46.
MooreLJ (1997) ‘It’s like you use pots and pans to cook. It’s the tool’: The technologies of safer sex. Science, Technology, & Human Values22(4): 434–471.
47.
MortMMayCFinchTMairF (2004) Telemedicine and clinical governance: Controlling technology, containing knowledge. In: GrayAHarrisonS (eds) Governing Medicine: Theory and Practice. Maidenhead, UK: Open University Press, 107–121.
48.
NguyenV-K (2005) Anti-retroviral globalism, biopolitics, and therapeutic citizenship. In: OngACollierS (eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. Malden, MA: Blackwell, 124–144.
49.
OudshoornN (1994) Beyond the Natural Body: An Archaeology of Sex Hormones. New York and London: Routledge.
50.
PadianN (1988) Prostitute women and AIDS: Epidemiology. AIDS2(6): 413–419.
51.
PetrynaA (2009) When Experiments Travel. Clinical Trials and the Global Search for Human Subjects. Princeton and Oxford: Princeton University Press.
52.
PetrynaALakoffAKleinmanA (2006) Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke University Press.
53.
Pharmaco-Economics Working Group of the Rockefeller Foundation Microbicide Initiative (2002) The Economics of Microbicide Development: A Case for Investment. New York: Rockefeller Foundation.
54.
PollockA (2011) Transforming the critique of Big Pharma. BioSocieties6: 106–118.
55.
ReaneyP (2004) Expert: Face of AIDS epidemic is an African woman. Reuters NewMediaLondon, 6July.
56.
RosenbergMJWeinerJM (1988) Prostitutes and AIDS: A health department priority?American Journal of Public Health78(4): 418–423.
57.
RosengartenMMichaelM (2009) Rethinking the biomedical enactment of medically drugged bodies: Paradoxes of using anti-HIV drug therapy as a technology for prevention. Science as Culture18(2): 183–199.
ShrumW (2000) Science and story in development: The emergence of non-governmental organizations in agricultural research. Social Studies of Science30(1): 95–124.
60.
SteinZA (1990) HIV prevention: The need for methods women can use. American Journal of Public Health80: 460–462.
TreichlerPA (1999) How to Have Theory in an Epidemic: Cultural Chronicles of AIDS. Durham and London: Duke University Press.
63.
Van DammeLRamjeeGAlaryMVuylstekeBChandeyingVReesH. (2002) Effectiveness of COL-1492, a Nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet360: 971–977.
64.
Van de PerrePClumeckNCaraelMNzabihimanaERobert-GuroffMDe MolP. (1985) Female prostitutes: A risk group for infection with human T-cell lymphotropic virus type III. Lancet326(8454): 524–527.
65.
Van der VeldenMMörtbergC (2011) Between need and desire: Exploring strategies for gendering design. Science, Technology, & Human Values doi: 10.1177/0162243911401632.
66.
Van OostE (2003) Materialized gender. How shavers configure the users’ femininity and masculinity. In: OudshoornNPinchT (eds) How Users Matter. The Co-Construction of Users and Technology. Cambridge, MA: MIT Press: 193–208.
67.
WaldbyC (1996) AIDS and the Body Politic: Biomedicine and Sexual Difference. London and New York: Routledge.
68.
WeberJDesaiKDarbyshireJ, on behalf of the Microbicides Development Programme (2005) The development of vaginal microbicides for the prevention of HIV transmission. PLoS Medicine2(5): e142
69.
WilliamsSJMartinPGabeJ (2011) The pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness33(5): 710–725.
70.
WiltonT (1997) EnGendering AIDS: Deconstructing Sex, Text and Epidemic. London: Sage Publications.
71.
WinthereikBRJohannsenNStrandDL (2008) Making technology public: Challenging the notion of script through an e-health demonstration video. Information, Technology & People21: 116–132.
72.
WoodsongC (2004) Covert use of topical microbicides: Implications for acceptability and use. International Family Planning Perspectives30(2): 94–98.
73.
WoolgarS (1991) Configuring the user: The case of usability trials. In: LawJ (ed.) A Sociology of Monsters. Essays on Power, Technology and Dominations. London: Routledge: 57–102.
